Features of Clinical Register of Chinese Medicine and Pharmacy Based on ClinicalTrials.gov. (USA).
- Author:
Peng-fei LU
;
Xing LIAO
;
Yan-ming XIE
;
Zhi-guo WANG
- Publication Type:Journal Article
- MeSH:
Biomedical Research;
China;
Clinical Trials as Topic;
Databases, Factual;
Humans;
Medicine, Chinese Traditional;
United States
- From:
Chinese Journal of Integrated Traditional and Western Medicine
2015;35(11):1388-1392
- CountryChina
- Language:Chinese
-
Abstract:
In recent 10 years, clinical trials of Chinese medicine and pharmacy (cMP) at clinicalTrials.gov.(USA) are gradually increasing. In order to analyze features of CMP clinical register, ClinicalTrials.gov register database were comprehensively retrieved in this study. Included clinical trials were input one item after another using EXCEL. A final of 348 CMP clinical trials were included. Results showed that China occupied the first place in CMP clinical register, followed by USA. CMP clinical trials, sponsored mainly by colleges/universities and hospitals, mostly covered interventional studies on evaluating safety/effectiveness of CMP. The proportions of studies, sponsored by mainland China and companies, recruitment trials and multi-center clinical trials in interventional trials were increasing. The proportions of studies sponsored by Hong Kong and Taiwan, research completed trials, unclear research status, phase III clinical trials, and published research trials in interventional trials were decreasing. Published ratios of CMP clinical trials were quite low. There were more missing types and higher proportions in trial register information.
